BiondVax Pharmaceuticals Ltd. (BVXV)

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for BVXV stock is $9.69, which predicts an increase of 728.21%. The lowest target is $7.07 and the highest is $12.6. On average, analysts rate BVXV stock as a buy.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.07	$9.69	$9.69	$12.6
Change	+504.27%	+728.21%	+728.21%	+976.92%

Analyst Ratings

The average analyst rating for BVXV stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '21	Feb '22	Mar '22	Apr '22	May '22	Jun '22
Strong Buy	2	2	2	2	2	2
Buy	4	4	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.42

from -2.80

EPS Next Year

-0.46

from -0.42

from -0.42

Year	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-	-	-
EPS	-6.80	-13.60	-13.20	-0.40	-2.80	-0.42	-0.46	-0.02	-0.03	-0.04
EPS Growth	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3	1	1

Revenue Forecast

Revenue	2022	2023	2024	2025	2026
High	n/a	n/a	n/a	n/a	n/a
Avg	n/a	n/a	n/a	n/a	n/a
Low	n/a	n/a	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-

EPS Forecast

EPS	2022	2023	2024	2025	2026
High	-0.02	-0.02	-0.02	-0.03	-0.04
Avg	-0.42	-0.46	-0.02	-0.03	-0.04
Low	-0.79	-0.87	-0.02	-0.03	-0.04

EPS Growth

EPS Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-